Therapeutic Nuclear Drug Market Valued to Reach USD $4.27 Billion by 2030 at 14.3% CAGR


 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Will the Market Growth Rate of the Therapeutic Nuclear Drug Market Impact Future Demand?
The therapeutic nuclear drug market size has grown rapidly in recent years. It will grow from $2.19 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing cancer prevalence, early adoption of iodine-131 in thyroid disorders, limited availability of targeted oncology therapies, growth of nuclear medicine departments, rising clinical acceptance of radiopharmaceuticals.

The therapeutic nuclear drug market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to development of novel therapeutic isotopes, expansion of precision oncology approaches, increasing investment in nuclear medicine infrastructure, growing clinical trials for radioligand therapies, favorable regulatory approvals for targeted nuclear drugs. Major trends in the forecast period include rising adoption of targeted radiopharmaceutical therapies, increasing use of lutetium-177 and alpha-emitting isotopes, growth in cancer-specific nuclear drug applications, expansion of combination therapies with nuclear drugs, strengthening focus on safety dosimetry and regulatory compliance.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/therapeutic-nuclear-drug-global-market-report

What Are the Key Growth Factors Supporting the Therapeutic Nuclear Drug Market Expansion?
The increasing prevalence of cancer is expected to propel the growth of the therapeutic nuclear drug market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells. The prevalence of cancer is due to improved detection and diagnosis, lifestyle factors, environmental exposures, and genetic factors. Therapeutic nuclear drugs act as a valuable component in the arsenal against cancer, providing targeted and effective treatment options for patients by reducing tumor size, alleviating symptoms, and improving quality of life. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the therapeutic nuclear drug market.

What Are the Key Segment Classifications in the Therapeutic Nuclear Drug Market?
The therapeutic nuclear drug market covered in this report is segmented –

1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types
2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes
3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications

What Are the Most Prominent Trends Impacting the Therapeutic Nuclear Drug Market?
Major companies operating in the therapeutic nuclear drug market are advancing targeted radiotherapies by showcasing novel multi-tumor treatment potential through emerging clinical data. These efforts aim to strengthen innovation pipelines, expand therapeutic applications, and accelerate adoption of next-generation radiopharmaceuticals. For instance, in 2025, Actinium Pharmaceuticals, a US-based clinical-stage biopharmaceutical company, launched a new data for ATNM-400, its first-in-class Actinium-225 radiotherapy, demonstrating multi-tumor potential including in non-small cell lung cancer (NSCLC). The findings were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. ATNM-400 is designed to deliver highly potent alpha-particle therapy with precision targeting, supporting its potential as a transformative therapeutic platform across multiple solid tumors. This advancement highlights the industry’s focus on expanding clinical applications of actinium-based radiotherapies to improve patient outcomes and broaden market opportunities.

Who Are the Key Players Driving the Therapeutic Nuclear Drug Market?
Major companies operating in the therapeutic nuclear drug market are Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals

Get the full therapeutic nuclear drug market report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-nuclear-drug-global-market-report

Which regions are expected to experience the fastest growth in the Therapeutic Nuclear Drug Market?
North America was the largest region in the therapeutic nuclear drug market in 2025. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Train And Components Market Report 2025 – Strategic Data for Growth and Expansion

Image
  Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the anticipated market size of the train and components industry over the next few years? The train and components market size has grown strongly in recent years. It will grow from $245.66 billion in 2024 to $266.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to economic conditions, urbanization, government investment, environmental concerns. The train and components market size is expected to see strong growth in the next few years. It will grow to $354.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to high-speed rail expansion, sustainable transport, electrification, freight rail expansion, regulatory compliance. Major trends in the forecast period include electrification and lightweighting, advan...
Read more

Construction Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts What is the current market size of the construction industry, and what growth rate is it expected to achieve? The construction market size has grown strongly in recent years. It will grow from $16152.39 billion in 2024 to $17045.95 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the increasing infrastructure development, the increase in renovation activities, rapid growth in the elderly population, and the rise in domestic manufacturing. The construction market size is expected to see strong growth in the next few years. It will grow to $21260.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising urbanization, increasing population growth, increasing government support, rising industrialization, and an increase ...
Read more

Global Fire Retardant Welding Blanket Market Report 2025: Market Opportunities & Challenges Outlook

Image
  For organizations targeting expansion, this report delivers actionable intelligence on how the fire retardant welding blanket industry is evolving. How Big Is The Fire Retardant Welding Blanket Market In 2025? The fire retardant welding blanket market size has grown strongly in recent years. It will grow from $1.22 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising use of asbestos alternatives in thermal protection, growing deployment of welding blankets in shipbuilding, increasing fire incidents in manufacturing facilities, rising preference for reusable fire safety equipment, and growing reliance on manual welding techniques. The fire retardant welding blanket market size is expected to see strong growth in the next few years. It will grow to $1.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing a...
Read more